Physician

Allison Marie Prinz, MD

According to 2025 Medicare claims, Allison Prinz, MD (NPI: 1245425131) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Lincoln, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1336492008; TIN: 56-0529945) and primary practice location at 28092-4133. Prinz is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Prinz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 250 traditional Medicare patients, billed 636 HCPCS/CPT codes, and received $46,564 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,312 prescription claims across 225 beneficiaries totaling $4,083,521 in drug costs, led by Calquence (Acalabrutinib Maleate). 2021 DME data shows 36 claims. Open Payments data shows 11 records totaling $239. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $99,703 to $46,564. In contrast, Part D prescription costs have moved sharply higher in recent years, from $415,971 to $4,083,521. For DME billing, this smaller-volume category fell sharply in recent years, from $2,872 to $934.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	229	4,337	$99,703
2016	266	992	$64,246
2017	298	1,131	$73,715
2018	329	1,168	$75,895
2019	324	981	$61,812
2020	280	834	$54,943
2021	302	839	$66,215
2022	283	768	$54,660
2023	251	999	$52,073
2024	250	636	$46,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	89	602	$415,971
2016	95	561	$622,094
2017	108	709	$1,080,934
2018	146	920	$1,169,846
2019	151	944	$1,501,471
2020	179	1,089	$1,605,739
2021	192	1,000	$1,964,966
2022	199	1,145	$2,472,805
2023	198	1,123	$2,921,469
2024	225	1,312	$4,083,521

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$26,257
2016	N/R	80	$21,790
2017	N/R	45	$12,090
2018	N/R	23	$1,363
2019	N/R	11	$867
2020	N/R	49	$3,907
2021	N/R	36	$2,836
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	24	24	$127
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	54	99	$103
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	13	13	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	452	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	26	31	$39

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	68	2,040	$722,820
Revlimid	Lenalidomide	36	1,008	$684,638
Ayvakit	Avapritinib	14	366	$507,482
Imbruvica	Ibrutinib	24	672	$371,169
Brukinsa	Zanubrutinib	25	750	$362,072

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$239	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allison Marie Prinz, MD?

Tedicare shows public-source Medicare data for Allison Marie Prinz, MD (NPI 1245425131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison Marie Prinz, MD have ACO affiliation data?

Allison Marie Prinz, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Allison Marie Prinz, MD?

Allison Marie Prinz, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1336492008) in the available physician profile data.

Does Allison Marie Prinz, MD have Open Payments data?

Allison Marie Prinz, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.